Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
Ruol
Alberto
A
Department of Surgical and Gastrointestinal Sciences, Clinica Chirurgica I, University of Padova, Padova, Italy. alberto.ruol@unipd.it
Rizzetto
Christian
C
Castoro
Carlo
C
Cagol
Matteo
M
Alfieri
Rita
R
Zanchettin
Gianpietro
G
Cavallin
Francesco
F
Michieletto
Silvia
S
Da Dalt
Gianfranco
G
Sileni
Vanna Chiarion
VC
Corti
Luigi
L
Mantoan
Silvia
S
Zaninotto
Giovanni
G
Ancona
Ermanno
E
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D016629:Esophagectomy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome